Customizing T cell biology: armoring approaches to optimize allogeneic CAR-T therapies

Immuno-Oncology Insights 2022; 3(10), 449–452

DOI: 10.18609/ioi.2022.048

Published: 28 November 2022
Viewpoint
Jakob Dupont


 “Within the past couple of decades, significant progress has been made in the landscape of immunotherapy, altering how certain cancers are treated.”